Results 231 to 240 of about 4,370,794 (311)

Disparate estimates of intrinsic productivity for Antarctic krill across small spatial scales under a rapidly changing ocean. [PDF]

PLoS One
Mardones M, Jarvis Mason E, Santa Cruz F, Watters G, Cárdenas C.   +4 more
europepmc   +1 more source

Affective dimensions in the information behavior of forcibly displaced people: A literature review. An Annual Review of Information Science and Technology (ARIST) paper

Journal of the Association for Information Science and Technology, EarlyView.
Abstract This review analyzed 241 scholarly articles published between 2010 and 2025 in information science venues to examine how affect shapes refugees' information behavior during forced migration and to identify additional contextual factors. It identifies seven affective dimensions: anxiety, shame and stigma, grief and loss, frustration, (mis)trust,
Maja Krtalić, Lilach Alon
wiley   +1 more source

Recreational fisheries as indicators of change: species range shifts from MRIP (1981-2024). [PDF]

BMC Zool
Roday RE, Hudock RE, Millea DR, Carlisle AB, Hale EA.   +4 more
europepmc   +1 more source

Conceptualizing algorithmic inequality and future agenda. An annual review of information science and technology (ARIST) paper

Journal of the Association for Information Science and Technology, EarlyView.
Abstract The issue of inequality caused by algorithms, termed ‘algorithmic inequality’, has recently attracted scholarly attention in many disciplines due to its profound implications for society. While the body of literature on algorithmic inequality has grown, there remains a lack of comprehensive understanding of its nature, drivers, and impact ...
Shiwei Jia, Jia Tina Du, Hui Yan
wiley   +1 more source

Trapping <i>Callinectes sapidus</i> (Atlantic Blue Crab) in the Mediterranean: What Can Be Learned from <i>Carcinus maenas</i> (European Green Crab) Pest Management. [PDF]

Animals (Basel)
Burnett JW, Ohnstad H, Hardege JD, Bartels-Hardege HD.   +3 more
europepmc   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Community-centered approaches to aquaculture in small-scale fisheries. [PDF]

Ambio
Castillo LS, Knott C, Quintana ACE, Spalding AK, Aceves-Bueno E, Blythe J, Rivera A, Basnett B.   +7 more
europepmc   +1 more source

Environmental impact of antidepressants: Is a new prescription framework possible?

British Journal of Clinical Pharmacology, EarlyView.
Aims Antidepressants such as venlafaxine and sertraline pose high risks to water ecosystems. As depressive disorders and other mental health conditions become increasingly prevalent worldwide, prescription and environmental presence of these pharmaceuticals continue to rise. This study explores the practical viability of a new framework for prescribing
Matilde Bianconi, Valentina Giunchi, Michael Thiede, Elisa Sangiorgi, Marco Menchetti, Elisabetta Poluzzi   +5 more
wiley   +1 more source

Reforming Spartina alterniflora policies for sustainable coastal resilience: an evidence-based adaptive strategy. [PDF]

NPJ Biodivers
Wang F, Wang H, Yu Q, Yang P, Gao S, Hu Y, Lu X.   +6 more
europepmc   +1 more source

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

British Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou, Alexander T. Cohen, Lucy Vernon, Victoria Collings, Ubonphan Chaichana, Natasha Moore, Hamda Jibril, Li Wei, Nicola Kumar, Karen A. Breen, Andrew J. Doyle   +10 more
wiley   +1 more source